| Pharmaceutical active ingredients: |
| Docusate SodiumSorbitol |
| Available forms, composition and doses of Yal: |
| Solution; Oral; Docusate Sodium 0.15 mg; Sorbitol 198.5 mg / ml |
| Yal medical category: |
| Human:Cathartics and laxativesLaxatives (general) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A06AD18 - SorbitolA06AG07 - SorbitolA06AG10 - Docusate Sodium, including combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Gebro PharmaAfamia TradeJacoby PharmazeutikaR-MarkTrommsdorff Arzneimittel |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Klyx | Docusate Sodium; Sorbitol | Ferring; Pharmachemie |
| Klyxenema | Docusate Sodium; Sorbitol | Ferring; B. Braun |
| Macrolax | Docusate Sodium; Sorbitol | Pfizer |
| Prontoclisma | Docusate Sodium; Sorbitol | Ecobi Farmaceutici |
| Sorbiclis | Docusate Sodium; Sorbitol | Specialita Igienico Terapeutiche |
| Hemorhin | Docusate Sodium; Spermaceti | B L Hua |
| Dermeol | Dodeclonium Bromide; Enoxolone | Cooperation Pharmaceutique Francaise |
| Freka-Feindesinfektion | Dodecyl-1,4,7-Triazaoctan-8-Carbonic Acid Hydrochloride | Fresenius |
| Korsolex AF | Dodecylbispropylenetriamine; Laurylpropylenediamine | Bode Chemie |
| Myxal S | Dodecyltriphenylphosphonium Bromide | Galderma |